Incyte Corp (NASDAQ:INCY)
CAPS Rating:
The Company is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs.
Growing the love for investing
The Company is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
As someone who suffers from psoriasis, there are not a lot of effective treatments on the market. Incyte's drug candidate for Psoriasis will do very well once it has FDA approval and if they also get approval for a topical solution to treat mild to moderate psoriasis this could be a home run revenue producer.